Nan Jin

2.0k total citations · 1 hit paper
53 papers, 1.4k citations indexed

About

Nan Jin is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Nan Jin has authored 53 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 13 papers in Oncology and 8 papers in Epidemiology. Recurrent topics in Nan Jin's work include Cytomegalovirus and herpesvirus research (5 papers), HER2/EGFR in Cancer Research (5 papers) and Hematopoietic Stem Cell Transplantation (5 papers). Nan Jin is often cited by papers focused on Cytomegalovirus and herpesvirus research (5 papers), HER2/EGFR in Cancer Research (5 papers) and Hematopoietic Stem Cell Transplantation (5 papers). Nan Jin collaborates with scholars based in China, Germany and United States. Nan Jin's co-authors include Bing Leng, Yana Jin, Ling Chen, Ge Li, Min Huang, Meiyu Geng, Shuai Tang, Michael Schmitt, Jiju Mani and Jian Ding and has published in prestigious journals such as Nature Materials, SHILAP Revista de lepidopterología and The Journal of Cell Biology.

In The Last Decade

Nan Jin

51 papers receiving 1.4k citations

Hit Papers

Socioeconomic status and hypertension 2014 2026 2018 2022 2014 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nan Jin China 17 503 202 193 179 148 53 1.4k
Xiaoling Wu China 21 475 0.9× 256 1.3× 58 0.3× 219 1.2× 214 1.4× 81 1.5k
Nicole P. Sandhu United States 20 344 0.7× 389 1.9× 465 2.4× 185 1.0× 122 0.8× 45 1.7k
Lei Yin China 28 865 1.7× 174 0.9× 328 1.7× 421 2.4× 250 1.7× 120 2.3k
Kinjal Shah Sweden 14 462 0.9× 352 1.7× 245 1.3× 104 0.6× 137 0.9× 33 1.6k
Chunling Xu China 17 429 0.9× 192 1.0× 78 0.4× 111 0.6× 270 1.8× 39 1.2k
Jing Zeng China 24 490 1.0× 175 0.9× 104 0.5× 162 0.9× 282 1.9× 117 1.6k
Ben Zhang China 20 647 1.3× 242 1.2× 160 0.8× 250 1.4× 167 1.1× 89 1.8k
Qing Ruan China 20 405 0.8× 212 1.0× 89 0.5× 275 1.5× 62 0.4× 98 1.6k
Yuanyuan Kong China 26 553 1.1× 172 0.9× 107 0.6× 199 1.1× 659 4.5× 162 2.2k
Li Song China 26 503 1.0× 295 1.5× 36 0.2× 174 1.0× 122 0.8× 117 2.0k

Countries citing papers authored by Nan Jin

Since Specialization
Citations

This map shows the geographic impact of Nan Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nan Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nan Jin more than expected).

Fields of papers citing papers by Nan Jin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nan Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nan Jin. The network helps show where Nan Jin may publish in the future.

Co-authorship network of co-authors of Nan Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Nan Jin. A scholar is included among the top collaborators of Nan Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nan Jin. Nan Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jin, Nan, et al.. (2025). Neural stem cell heterogeneity in adult hippocampus. Cell Regeneration. 14(1). 6–6. 2 indexed citations
2.
Liu, Jingwen, et al.. (2025). MiRNA- 1293 Promotes Hepatocellular Carcinoma Cell Proliferation and Invasion by METTL3-Mediated m6 A Modification of Pri-miRNA- 1293. Applied Biochemistry and Biotechnology. 197(7). 4409–4422. 1 indexed citations
4.
Huang, Xiang, Nan Jin, Chunxiao Sun, et al.. (2024). Abstract PO1-04-04: Inetetamab combined with pyrotinib and oral vinorelbine for patients with HER2-positive metastatic breast cancer: a single-arm phase 2 trial. Cancer Research. 84(9_Supplement). PO1–4. 1 indexed citations
5.
Jin, Nan, et al.. (2024). Vertical variation in leaf functional traits of Parashorea chinensis with different canopy layers. Frontiers in Plant Science. 15. 1335524–1335524. 7 indexed citations
7.
Jin, Nan, Yongmei Yin, Wěi Li, & Xuanzhang Huang. (2023). 69P A multicenter, retrospective, real-world study of inetetamab combined with pyrotinib and vinorelbine as treatment for HER2-positive metastatic breast cancer. Annals of Oncology. 34. S1492–S1492. 1 indexed citations
8.
Zhang, Huadong, Yuan Fang, Nan Jin, & Huaxin Deng. (2023). The Combined Effect of Elevated Blood Pressure and Occupational Noise Exposure on Bilateral High-Frequency Hearing Loss. Journal of Occupational and Environmental Medicine. 65(4). e219–e226. 6 indexed citations
9.
Wang, Yingying, Zhen Zhu, Ke Liu, et al.. (2022). A high-throughput microfluidic diploid yeast long-term culturing (DYLC) chip capable of bud reorientation and concerted daughter dissection for replicative lifespan determination. Journal of Nanobiotechnology. 20(1). 171–171. 7 indexed citations
10.
Yang, Xin, Nan Jin, Yu Wang, et al.. (2021). Macroautophagy supports Sonic Hedgehog signaling by promoting Patched1 degradation. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1868(12). 119124–119124. 5 indexed citations
11.
Jin, Nan, et al.. (2020). Alterations and molecular targeting of the GSK-3 regulator, PI3K, in head and neck cancer. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1867(6). 118679–118679. 18 indexed citations
12.
Zeng, Hanlin, Jia Qu, Nan Jin, et al.. (2016). Feedback Activation of Leukemia Inhibitory Factor Receptor Limits Response to Histone Deacetylase Inhibitors in Breast Cancer. Cancer Cell. 30(3). 459–473. 134 indexed citations
13.
Zhang, Dongda, Nan Jin, Wei Sun, et al.. (2016). Phosphoglycerate mutase 1 promotes cancer cell migration independent of its metabolic activity. Oncogene. 36(20). 2900–2909. 72 indexed citations
14.
Sun, Wenyi, Zuoquan Xie, Yifu Liu, et al.. (2015). JX06 Selectively Inhibits Pyruvate Dehydrogenase Kinase PDK1 by a Covalent Cysteine Modification. Cancer Research. 75(22). 4923–4936. 69 indexed citations
15.
Lorenz, Katrin, Jiju Mani, Nan Jin, et al.. (2014). Modulation of lymphocyte subpopulations by extracorporeal photopheresis in patients with acute graft-versus-host disease or graft rejection. Leukemia & lymphoma. 56(3). 671–675. 11 indexed citations
16.
Mani, Jiju, Nan Jin, & Michael Schmitt. (2014). Cellular immunotherapy for patients with reactivation of JC and BK polyomaviruses after transplantation. Cytotherapy. 16(10). 1325–1335. 26 indexed citations
17.
Lü, Zhaohui, Guoqing Yang, Jing–tao Dou, et al.. (2013). Clinical characteristic analysis of 742 hospitalized cases with type 1 diabetes mellitus. 5(2). 89–93. 1 indexed citations
18.
Chen, Ping, Guoqing Yang, Jing–tao Dou, et al.. (2013). Hospital prevalence, mortality and risk of inpatients with type 2 diabetes mellitus: a retrospective study. 5(6). 332–337. 1 indexed citations
19.
Jin, Nan, Georg Malcherek, Jiju Mani, et al.. (2013). Suppression of cytomegalovirus-specific CD8+T cells by everolimus. Leukemia & lymphoma. 55(5). 1144–1150. 5 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026